DK1325749T3 - Knoglemetabolismeforbedrende middel - Google Patents

Knoglemetabolismeforbedrende middel

Info

Publication number
DK1325749T3
DK1325749T3 DK01970265T DK01970265T DK1325749T3 DK 1325749 T3 DK1325749 T3 DK 1325749T3 DK 01970265 T DK01970265 T DK 01970265T DK 01970265 T DK01970265 T DK 01970265T DK 1325749 T3 DK1325749 T3 DK 1325749T3
Authority
DK
Denmark
Prior art keywords
bone metabolism
improving agent
soybean milk
metabolism enhancer
metabolism improving
Prior art date
Application number
DK01970265T
Other languages
English (en)
Inventor
Satoshi Matsubara
Hiroko Hayakawa
Yasuhisa Shimakawa
Mitsuyoshi Kano
Harue Sone
Fumiyasu Ishikawa
Original Assignee
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Kk filed Critical Yakult Honsha Kk
Application granted granted Critical
Publication of DK1325749T3 publication Critical patent/DK1325749T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A23C11/106—Addition of, or treatment with, microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/50—Fermented pulses or legumes; Fermentation of pulses or legumes based on the addition of microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60—Drinks from legumes, e.g. lupine drinks
    • A23L11/65—Soy drinks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Botany (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Endocrinology (AREA)
  • Sustainable Development (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
DK01970265T 2000-10-13 2001-09-28 Knoglemetabolismeforbedrende middel DK1325749T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000313223 2000-10-13
PCT/JP2001/008486 WO2002032441A1 (en) 2000-10-13 2001-09-28 Bone metabolism improving agent

Publications (1)

Publication Number Publication Date
DK1325749T3 true DK1325749T3 (da) 2007-02-12

Family

ID=18792674

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01970265T DK1325749T3 (da) 2000-10-13 2001-09-28 Knoglemetabolismeforbedrende middel

Country Status (12)

Country Link
US (2) US20040013656A1 (da)
EP (1) EP1325749B1 (da)
JP (1) JP4880861B2 (da)
KR (1) KR20030048427A (da)
CN (1) CN100548320C (da)
AT (1) ATE342725T1 (da)
AU (1) AU2001290302A1 (da)
DE (1) DE60123986T2 (da)
DK (1) DK1325749T3 (da)
ES (1) ES2273888T3 (da)
PT (1) PT1325749E (da)
WO (1) WO2002032441A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004154086A (ja) * 2002-11-08 2004-06-03 Satoshi Saito 麹・豆乳入りヨーグルト食品とその製造方法
JP2004315477A (ja) * 2003-04-18 2004-11-11 Tokyoto Koreisha Kenkyu Fukushi Shinko Zaidan 骨吸収抑制剤
US7332188B2 (en) * 2004-11-22 2008-02-19 T.F.H. Publications, Inc. Animal chew containing fermented soyfood
US8182855B2 (en) * 2004-11-22 2012-05-22 T.F.H. Publications, Inc. Fish food containing fermented soyfood
EP1891967B1 (en) * 2006-08-24 2019-11-20 Société des Produits Nestlé S.A. Long-lasting absorption of flavonoids
US8227013B2 (en) * 2007-06-29 2012-07-24 Vijaya Nair Dietary nutritional supplements for healthcare
JP5255262B2 (ja) * 2007-11-20 2013-08-07 旭化成ケミカルズ株式会社 発酵果汁
JP5322046B2 (ja) * 2008-05-02 2013-10-23 国立大学法人広島大学 骨強化補助食品
ITMI20091034A1 (it) * 2009-06-11 2010-12-12 Parmalat Spa Specie probiotica di bifidobacterium breve
DE202012104505U1 (de) 2012-11-21 2013-01-17 Petra Stanczyk Nahrungsmittel für Tiere, insbesondere Hunde, Katzen und Pferde
CN103431053B (zh) * 2013-07-31 2016-03-02 吉林农业大学 一种凝固型发酵豆奶和搅拌型发酵豆奶的生产方法
US9980993B2 (en) 2014-11-06 2018-05-29 NWO Stem Cure, LLC Nutraceutical supplement with Lactobacillus rhamnosus
US9468659B2 (en) * 2014-11-06 2016-10-18 NWO Stem Cure, LLC Nutraceutical supplement with Lactobacillus rhamnosus
MY187271A (en) * 2015-02-17 2021-09-17 Yakult Honsha Kk Method for producing fermented milk food
EA039591B1 (ru) * 2015-10-30 2022-02-15 Кабусики Кайся Якулт Хонса Способ получения осушенных микробных клеток
CN110959676B (zh) * 2018-09-30 2022-11-25 内蒙古伊利实业集团股份有限公司 一种含乳双歧杆菌的发酵乳制品及其应用
CA3208064A1 (en) 2021-02-10 2022-08-18 Zhongke Wisbiom（Beijing）Biotechnology Co., Ltd. Bifidobacterium animalis subsp. lactis and use thereof
CN116904378B (zh) * 2023-09-14 2023-12-29 山东中科嘉亿生物工程有限公司 促进骨成长的约氏乳杆菌jylo-010及菌剂、应用
CN118370366B (zh) * 2024-04-10 2024-11-19 东北农业大学 格氏乳杆菌jm1的发酵方法及其应用
CN120330110B (zh) * 2025-06-13 2025-11-07 内蒙古蒙牛乳业（集团）股份有限公司 动物双歧杆菌乳亚种Ca360及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05176718A (ja) * 1991-12-27 1993-07-20 Kiichiro Sarui 低塩低カロリーの食品基材並びに食品用調味料の製造方法
JPH05268907A (ja) * 1992-03-26 1993-10-19 Ogawa Koryo Kk カルシウム強化発酵タンパク組成物
JP3280420B2 (ja) 1992-07-30 2002-05-13 株式会社紀文フードケミファ 豆乳を含むカルシウム吸収促進組成物
JP3260491B2 (ja) 1993-06-30 2002-02-25 株式会社紀文フードケミファ 豆乳タンパク質高分子画分または豆乳ペプチドを含むカルシウム吸収促進組成物
JPH09191852A (ja) * 1996-01-19 1997-07-29 Sennosuke Tokumaru 健康食品
JP3529421B2 (ja) * 1994-04-18 2004-05-24 三栄源エフ・エフ・アイ株式会社 カルシウム強化酸性蛋白飲料の製造法
JPH09194384A (ja) * 1996-01-19 1997-07-29 Snow Brand Milk Prod Co Ltd ミネラル吸収促進剤
JP3489930B2 (ja) * 1996-03-08 2004-01-26 株式会社ヤクルト本社 がん予防食品
JP3505043B2 (ja) * 1996-08-14 2004-03-08 株式会社ヤクルト本社 ビタミンｋ補給食品および骨粗鬆症予防・治療用食品
JPH10114653A (ja) * 1996-10-11 1998-05-06 Taishi Shokuhin Kogyo Kk 骨形成促進および骨塩量減少防止用組成物
JP3359827B2 (ja) * 1996-10-29 2002-12-24 株式会社ヤクルト本社 脂質代謝改善剤及びそれを含有する食品
JPH10158178A (ja) * 1996-11-29 1998-06-16 Yakult Honsha Co Ltd ミネラル吸収促進剤およびミネラル強化剤
JP3998293B2 (ja) * 1997-06-18 2007-10-24 株式会社ヤクルト本社 ヘリコバクター・ピロリ菌抑制剤
JP4046389B2 (ja) * 1997-09-04 2008-02-13 株式会社ヤクルト本社 ビフィドバクテリウム・ブレーベ及びこれを用いた発酵豆乳
JP3172150B2 (ja) * 1998-04-27 2001-06-04 株式会社ヤクルト本社 Ｇａｂａ含有飲食品の製造法
JP3320359B2 (ja) 1998-06-09 2002-09-03 太子食品工業株式会社 有機態亜鉛を添加した食品
JP2000053573A (ja) * 1998-08-11 2000-02-22 Yakult Honsha Co Ltd 肝機能改善剤
JP3430940B2 (ja) 1998-11-04 2003-07-28 不二製油株式会社 イソフラボンとペプチドを組み合わせた食品及び飲料
JP2000212079A (ja) * 1999-01-22 2000-08-02 Yakult Honsha Co Ltd ミネラル吸収促進剤

Also Published As

Publication number Publication date
CN1469750A (zh) 2004-01-21
PT1325749E (pt) 2007-01-31
AU2001290302A1 (en) 2002-04-29
ATE342725T1 (de) 2006-11-15
KR20030048427A (ko) 2003-06-19
EP1325749A4 (en) 2005-09-07
EP1325749A1 (en) 2003-07-09
JPWO2002032441A1 (ja) 2004-02-26
US20070298146A1 (en) 2007-12-27
ES2273888T3 (es) 2007-05-16
WO2002032441A1 (en) 2002-04-25
CN100548320C (zh) 2009-10-14
JP4880861B2 (ja) 2012-02-22
EP1325749B1 (en) 2006-10-18
DE60123986T2 (de) 2007-02-15
US20040013656A1 (en) 2004-01-22
US7754255B2 (en) 2010-07-13
DE60123986D1 (de) 2006-11-30

Similar Documents

Publication Publication Date Title
DK1325749T3 (da) Knoglemetabolismeforbedrende middel
EP1567660A4 (en) Merging fermented ginseng, lactose, yoghurt, and lactose used in the production of milk lactobacteria
EP0753303A3 (en) Physiologically functional food having brain function-improving, learning ability-enhancing, and memory-enhancing functions
EP1123655A4 (en) BACTERICIDE DISINFECTING PERACYRIC ACID COMPOSITION
WO2003005963A3 (en) Composition having bacteristatic and bactericidal activity against bacterial spores and vegetative cells and process for treating foods therewith
EP1112692A4 (en) Drinks and foods capable of eliminating helicobacter pylori
IL153989A0 (en) Nutritional composition
ATE400281T1 (de) Vaginales lactobacillus-medikament
MXPA03007881A (es) Bacterias productoras de acido lactico para tratar y prevenir la alergia.
ATE303070T1 (de) Herstellung von nahrungsmitteln durch fermentierung von sojamilch mit streptococcus thermophilus
AU2002243005A1 (en) Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
WO2003053474A3 (en) Use of micro-organisms for a directed delivery of substances to specific parts of the gut
MXPA02009342A (es) Uso de bacterias de acido lactico para el tratamiento de la peritonitis.
WO2004001020A3 (en) Methods and means to promote gut absorption
ATE451840T1 (de) Zur desinfektion von helicobacter pylori befähigter käse
AU9391601A (en) Ferment activator based of lactic acid bacteria and method for preparing a dairyproduct using same
BRPI0410444A (pt) processo e inóculo para fermentação láctica acidificante
DE69634917D1 (de) Milchsäurebakterien und ihre anwendung zur herstellung von hypercholesterolemische aktive produkte
WO2006041409A8 (en) Medical solution, method for producing and use thereof
AU2001262250A1 (en) Probiotic lactic acid bacteria, unable to utilize lactose
ATE291353T1 (de) Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen
AU2003286294A1 (en) Process to improve milk coagulation by means of strains of lactic bacteria, new strains and their use in said process
WO2003056025A3 (fr) Utilisation de bacteries lactiques pour la production d'alpha-cetoglutarate
UA31689C2 (en) Method for production of the fermented milk product "lactobion"
KR960003613A (ko) 유산균 변이주를 이용한 녹차 발효생균 음료의 제조방법